Gadopentetate Dimeglumine Injection/API
Since Gadopentetate Dimeglumine Injection was launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, and quickly occupied the market with its excellent quality and reasonable price. Up to now, linear gadolinium has been safely used for nearly 30 years, with excellent enhancement effects and few side effects.
Product name: Gadopentetate Dimeglumine Injection
Generic name: Gadopentetate Dimeglumine Injection
Type: Injectable Contrast Media for MRI, Linear Contrast Media
Ingredients: Gadopentetate Dimeglumine
Specification: 10ml:4.69 g; 12ml:5.63 g; 15ml:7.04 g; 20ml:9.38 g
Posology and method of administration: Intravenous injection
Adverse reactions: See the details from the package insert
Shelf life: 36 months
Indication of Gadopentetate Dimeglumine Injection
Magnetic resonance imaging of the central nervous system (brain and spinal cord), abdomen, chest, pelvis, limbs and other human organs and tissues.
Precautions of Gadopentetate Dimeglumine Injection
Current evidence shows that after repeated use of GBCAs, trace amounts of gadolinium can remain in the brain and other body tissues. Research reports have shown that multiple uses of GBCAs can increase the intensity of brain signals, especially in the dentate nucleus and globus pallidus. Currently, there are more reports about linear GBCAs and fewer reports about macrocyclic GBCAs. Animal experiments have shown that the amount of gadolinium deposited after repeated use of linear GBCAs is higher than that of repeated use of macrocyclic.
The clinical significance of brain gadolinium deposition is unclear.
In order to minimize the potential risks associated with gadolinium deposition in the brain, it must be used in strict accordance with the indications and approved doses. It is recommended to use the lowest approved dose that meets the requirement of diagnosis and perform a careful benefit-risk assessment and patient informed communication before repeated administration.
bei luisa professional contrast media manufacturing companies, we provide ct contrast agent, mri contrast medium and etc. Want to know more? Please contact us.
在线联系供应商
Other supplier products
 |
Traditional Chinese Medicine-Jiuweizhenxin Granules | As one of the best anti-anxiety drugs, Jiuweizhenxin Granules is a modern Chinese patent medicine independently developed by Beilu Pharma for the t... |
 |
Iohexol Injection | Iohexol Injection is a non-ionic Contrast Media. Compared with a traditional ionic Contrast Media, Iohexol Injection has an excellent molecular str... |
 |
Glimepiride Tablets | Glimepiride 1 Tabletis a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, glimepiride 2 tablet(Dibei), as the ... |
 |
Gadobenate Dimeglumine Injection | What's New at Beilu Beilu Pharmaceutical has been awarded BeiluPharmaceutical has been awarded "Beijing Advanced Unit of Adverse Drug Reactions D... |
 |
Gadopentetate Dimeglumine Injection/API | Since Gadopentetate Dimeglumine Injectionwas launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, ... |
Same products
 |
Chlortetracycline Premix | 卖方: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. | Precautions for the use of Chlortetracycline Premix in livestock feed 1. Strict compliance: &midd... |
 |
Chlortetracycline Premix | 卖方: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. | Chlortetracycline Premix in livestock and poultry feed: 1. Purpose: · Promote the growth o... |
 |
Chlortetracycline Premix | 卖方: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. | Uses of Chlortetracycline Premix ·Livestock and poultry health: Chlortetracycline Premix i... |
 |
Chlortetracycline Premix | 卖方: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. | Characteristics of Chlortetracycline Premix ·Natural fermentation products: Chlortetracycl... |
 |
Chlortetracycline Premix | 卖方: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. | Chlortetracycline Premix is a feed additive that combines chlortetracycline with premix technolog... |
